Dr. Apollina Sharma, Medical News Network writer recent study wrote about a recent study—see link https://www.ncbi.nlm.nih.gov/
The main criteria for including a study into their review were a large number of participants and at least 1000 patient-years of follow up. They drew up a meta-analysis from all the information covered by the wide span of data. Approximately 74 trials that represented 306,273 participants adding up to 1.2 million-person years were taken into account.
Starting systolic blood pressure was an important indicator of major cardiovascular events
The researchers found that the starting systolic blood pressure was an important indicator for evaluating the presence of major cardiovascular events if blood pressure lowering drugs were given. Systolic blood pressure is the highest pressure an individual’s heart can generate in order for blood to flow appropriately through the body. This pressure should generally be between 80 to 120 mmHg for most people. Individuals who generate a pressure lower or higher than this range are at risk for cardiovascular disease and require blood pressure medications.
Risk of death and heart disease decreased only if the systolic blood pressure was 140mmHg or higher before treatment
If the systolic blood pressure at the start of the studies was 160 mmHg or higher, then the reduction of blood pressure with the correct treatment regimen proved to greatly decrease the chances of having a cardiovascular risk. If the blood pressure baseline ranged between 140 to 159 mmHg, the association of mortality after taking the medication was similar even though the risk for cardiovascular events decreased. In individuals who had their blood pressure at less than 140 mmHg at the start of the study, blood pressure reduction through medication proved to not be as helpful in decreasing the rate of mortality and reducing major cardiovascular risk.Source: Medicine News Bulletin